Rahul Kumar

About

Dr. Rahul Kumar currently works as an Assistant Professor (Research) in the Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, USA. Dr Kumar’s research is mainly focused on designing and evaluating novel mitochondrial function modulators as anti-cancer agents and published more than 40 peer-reviewed research articles and book chapters. Dr Kumar also working on understanding the role of DNA damage repair pathways in Prostate cancer incidence and progression to develop novel therapeutics.

Employment

• Roswell Park Comprehensive Cancer Center Research Assistant Professor of Oncology
  2020 - Present
• Roswell Park Comprehensive Cancer Center Research Associate
  2018 - 2020
• Roswell Park Comprehensive Cancer Center Post Doctoral Fellow
  2015 - 2018
• University of Colorado - Anschutz Medical Campus Post Doctoral Research Associate
  2013 - 2015

Education

• Jamia Hamdard PhD
  2009 - 2013
• Govind Ballabh Pant University of Agriculture and Technology Masters
  2004 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (51)

• A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression
  Biomedicines 2025 DOI: 10.3390/biomedicines13010134
  +Save
• TGF-β1 Directs TFAM-Mediated Mitochondrial Reprogramming in Oral Submucous Fibrosis
  Journal of Dental Research 2025 DOI: https://doi.org/10.1177/00220345251394281
  +Save
• Mitochondrial unfolded protein response-dependent β-catenin signaling promotes neuroendocrine prostate cancer.
  Oncogene 2024 DOI: 10.1038/s41388-024-03261-4
  +Save
• Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells.
  Cell stem cell 2024 DOI: 10.1016/j.stem.2024.05.008
  +Save
• Abstract 2601: Lrig1 is a haplo-insufficient tumor suppressor and Lrig1-expressing cells can function as cells-of-origin of tumor development
  Cancer Research 2023 DOI: 10.1158/1538-7445.am2023-2601
  +Save
• Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells
  2023 DOI: 10.1101/2023.03.03.530998
  +Save
• A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60
  Journal of Clinical Investigation 2022 DOI: 10.1172/JCI149906
  +Save
• Targeting the mitochondrial unfolded protein response in cancer: opportunities and challenges
  Trends in Cancer 2021 DOI: 10.1016/j.trecan.2021.08.008
  +Save
• A Single-Organelle Optical Omics Platform for Cell Science and Biomarker Discovery.
  Analytical chemistry 2021 DOI: 10.1021/acs.analchem.1c01131
  +Save
• Slow-Cycling (Dormant) Cancer Cells in Therapy Resistance, Cancer Relapse and Metastasis.
  Seminars in cancer biology 2021 DOI: 10.1016/j.semcancer.2021.04.021
  +Save